Clinical Trials on Clinical Markers in Portugal
Total 10 results
-
Aveiro UniversityCompletedOlder Adults Without Any Specific Clinical ConditionPortugal
-
PfizerTerminatedAge-related Macular Degeneration (AMD) | Choroidal Neovascularization (CNV) | Early MarkersItaly, Portugal, United Kingdom
-
Hospital Garcia de OrtaCompleted
-
Centro Hospitalar De São João, E.P.E.CompletedClinically Significant Portal HypertensionPortugal
-
Universidade do PortoCompletedCritically Ill | Intracerebral Hemorrhage | Intracranial Pressure | Cerebral Perfusion Pressure | PrognosticPortugal
-
Centro Hospitalar de Lisboa CentralNOVA Medical SchoolUnknownCritical Illness | Cirrhosis, Liver | Ascites Hepatic | Paracentesis | Hypertension, IntraabdominalPortugal
-
AmgenCompletedBlincyto Use in Routine Clinical PracticeNetherlands, France, Czechia, Sweden, Austria, Italy, Switzerland, Germany, Finland, United Kingdom, Portugal, Greece, Poland
-
Ixaka LtdAndalusian Network for Design and Translation of Advanced TherapiesTerminatedCardiovascular Disease | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Critical Limb Ischemia (CLI) | Peripheral Arterial Disease (PAD) | Diabetes Mellitus (DM)Spain, Czechia, Portugal, Hungary, Germany, Poland
-
Ixaka LtdAndalusian Network for Design and Translation of Advanced TherapiesTerminatedCardiovascular Disease | Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | Critical Limb Ischemia (CLI) | Peripheral Arterial Disease (PAD) | Diabetes Mellitus (DM)Spain, Netherlands, United Kingdom, Czechia, Portugal, Hungary
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis | Clinically Isolated SyndromeCroatia, Bulgaria, France, Italy, Russian Federation, Spain, Estonia, Germany, Latvia, Poland, Romania, Argentina, Finland, Israel, Greece, Czech Republic, Slovakia, Austria, Belgium, Canada, Lebanon, Morocco, Portugal, Serbia